Global Impetigo Drug Market Research Report 2023

Report ID: 1970205 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Impetigo Drug Market Overview
    1.1 Product Overview and Scope of Impetigo Drug
    1.2 Impetigo Drug Segment by Type
        1.2.1 Global Impetigo Drug Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 FMX-102
        1.2.3 LTX-109
        1.2.4 Mupirocin
        1.2.5 Ozenoxacin
        1.2.6 Others
    1.3 Impetigo Drug Segment by Application
        1.3.1 Global Impetigo Drug Sales Comparison by Application: (2022-2028)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Others
    1.4 Global Impetigo Drug Market Size Estimates and Forecasts
        1.4.1 Global Impetigo Drug Revenue 2017-2028
        1.4.2 Global Impetigo Drug Sales 2017-2028
        1.4.3 Impetigo Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Impetigo Drug Market Competition by Manufacturers
    2.1 Global Impetigo Drug Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Impetigo Drug Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Impetigo Drug Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Impetigo Drug Manufacturing Sites, Area Served, Product Type
    2.5 Impetigo Drug Market Competitive Situation and Trends
        2.5.1 Impetigo Drug Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Impetigo Drug Players Market Share by Revenue
        2.5.3 Global Impetigo Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Impetigo Drug Retrospective Market Scenario by Region
    3.1 Global Impetigo Drug Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Impetigo Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Impetigo Drug Market Facts & Figures by Country
        3.3.1 North America Impetigo Drug Sales by Country
        3.3.2 North America Impetigo Drug Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Impetigo Drug Market Facts & Figures by Country
        3.4.1 Europe Impetigo Drug Sales by Country
        3.4.2 Europe Impetigo Drug Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Impetigo Drug Market Facts & Figures by Region
        3.5.1 Asia Pacific Impetigo Drug Sales by Region
        3.5.2 Asia Pacific Impetigo Drug Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Impetigo Drug Market Facts & Figures by Country
        3.6.1 Latin America Impetigo Drug Sales by Country
        3.6.2 Latin America Impetigo Drug Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Impetigo Drug Market Facts & Figures by Country
        3.7.1 Middle East and Africa Impetigo Drug Sales by Country
        3.7.2 Middle East and Africa Impetigo Drug Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Impetigo Drug Historic Market Analysis by Type
    4.1 Global Impetigo Drug Sales Market Share by Type (2017-2022)
    4.2 Global Impetigo Drug Revenue Market Share by Type (2017-2022)
    4.3 Global Impetigo Drug Price by Type (2017-2022)
5 Global Impetigo Drug Historic Market Analysis by Application
    5.1 Global Impetigo Drug Sales Market Share by Application (2017-2022)
    5.2 Global Impetigo Drug Revenue Market Share by Application (2017-2022)
    5.3 Global Impetigo Drug Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Destiny Pharma Ltd
        6.1.1 Destiny Pharma Ltd Corporation Information
        6.1.2 Destiny Pharma Ltd Description and Business Overview
        6.1.3 Destiny Pharma Ltd Impetigo Drug Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Destiny Pharma Ltd Impetigo Drug Product Portfolio
        6.1.5 Destiny Pharma Ltd Recent Developments/Updates
    6.2 Foamix Pharmaceuticals Ltd
        6.2.1 Foamix Pharmaceuticals Ltd Corporation Information
        6.2.2 Foamix Pharmaceuticals Ltd Description and Business Overview
        6.2.3 Foamix Pharmaceuticals Ltd Impetigo Drug Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Foamix Pharmaceuticals Ltd Impetigo Drug Product Portfolio
        6.2.5 Foamix Pharmaceuticals Ltd Recent Developments/Updates
    6.3 Fujifilm Holdings Corporation
        6.3.1 Fujifilm Holdings Corporation Corporation Information
        6.3.2 Fujifilm Holdings Corporation Description and Business Overview
        6.3.3 Fujifilm Holdings Corporation Impetigo Drug Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Fujifilm Holdings Corporation Impetigo Drug Product Portfolio
        6.3.5 Fujifilm Holdings Corporation Recent Developments/Updates
    6.4 Laboratories Ojer Pharma SL
        6.4.1 Laboratories Ojer Pharma SL Corporation Information
        6.4.2 Laboratories Ojer Pharma SL Description and Business Overview
        6.4.3 Laboratories Ojer Pharma SL Impetigo Drug Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Laboratories Ojer Pharma SL Impetigo Drug Product Portfolio
        6.4.5 Laboratories Ojer Pharma SL Recent Developments/Updates
    6.5 Lytix Biopharma AS
        6.5.1 Lytix Biopharma AS Corporation Information
        6.5.2 Lytix Biopharma AS Description and Business Overview
        6.5.3 Lytix Biopharma AS Impetigo Drug Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Lytix Biopharma AS Impetigo Drug Product Portfolio
        6.5.5 Lytix Biopharma AS Recent Developments/Updates
7 Impetigo Drug Manufacturing Cost Analysis
    7.1 Impetigo Drug Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Impetigo Drug
    7.4 Impetigo Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Impetigo Drug Distributors List
    8.3 Impetigo Drug Customers
9 Impetigo Drug Market Dynamics
    9.1 Impetigo Drug Industry Trends
    9.2 Impetigo Drug Market Drivers
    9.3 Impetigo Drug Market Challenges
    9.4 Impetigo Drug Market Restraints
10 Global Market Forecast
    10.1 Impetigo Drug Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Impetigo Drug by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Impetigo Drug by Type (2023-2028)
    10.2 Impetigo Drug Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Impetigo Drug by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Impetigo Drug by Application (2023-2028)
    10.3 Impetigo Drug Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Impetigo Drug by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Impetigo Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Impetigo Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
    Table 2. Global Impetigo Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
    Table 3. Global Impetigo Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Impetigo Drug Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Impetigo Drug Sales (K Pcs) of Key Manufacturers (2017-2022)
    Table 6. Global Impetigo Drug Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Impetigo Drug Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Impetigo Drug Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Impetigo Drug Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Impetigo Drug Manufacturing Sites and Area Served
    Table 11. Manufacturers Impetigo Drug Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Impetigo Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Impetigo Drug as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Impetigo Drug Sales by Region (2017-2022) & (K Pcs)
    Table 16. Global Impetigo Drug Sales Market Share by Region (2017-2022)
    Table 17. Global Impetigo Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Impetigo Drug Revenue Market Share by Region (2017-2022)
    Table 19. North America Impetigo Drug Sales by Country (2017-2022) & (K Pcs)
    Table 20. North America Impetigo Drug Sales Market Share by Country (2017-2022)
    Table 21. North America Impetigo Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Impetigo Drug Revenue Market Share by Country (2017-2022)
    Table 23. Europe Impetigo Drug Sales by Country (2017-2022) & (K Pcs)
    Table 24. Europe Impetigo Drug Sales Market Share by Country (2017-2022)
    Table 25. Europe Impetigo Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Impetigo Drug Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Impetigo Drug Sales by Region (2017-2022) & (K Pcs)
    Table 28. Asia Pacific Impetigo Drug Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Impetigo Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Impetigo Drug Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Impetigo Drug Sales by Country (2017-2022) & (K Pcs)
    Table 32. Latin America Impetigo Drug Sales Market Share by Country (2017-2022)
    Table 33. Latin America Impetigo Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Impetigo Drug Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Impetigo Drug Sales by Country (2017-2022) & (K Pcs)
    Table 36. Middle East and Africa Impetigo Drug Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Impetigo Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Impetigo Drug Revenue Market Share by Country (2017-2022)
    Table 39. Global Impetigo Drug Sales by Type (2017-2022) & (K Pcs)
    Table 40. Global Impetigo Drug Sales Market Share by Type (2017-2022)
    Table 41. Global Impetigo Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Impetigo Drug Revenue Share by Type (2017-2022)
    Table 43. Global Impetigo Drug Price by Type (2017-2022) & (USD/Pcs)
    Table 44. Global Impetigo Drug Sales (K Pcs) by Application (2017-2022)
    Table 45. Global Impetigo Drug Sales Market Share by Application (2017-2022)
    Table 46. Global Impetigo Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Impetigo Drug Revenue Share by Application (2017-2022)
    Table 48. Global Impetigo Drug Price by Application (2017-2022) & (USD/Pcs)
    Table 49. Destiny Pharma Ltd Corporation Information
    Table 50. Destiny Pharma Ltd Description and Business Overview
    Table 51. Destiny Pharma Ltd Impetigo Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 52. Destiny Pharma Ltd Impetigo Drug Product
    Table 53. Destiny Pharma Ltd Recent Developments/Updates
    Table 54. Foamix Pharmaceuticals Ltd Corporation Information
    Table 55. Foamix Pharmaceuticals Ltd Description and Business Overview
    Table 56. Foamix Pharmaceuticals Ltd Impetigo Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 57. Foamix Pharmaceuticals Ltd Impetigo Drug Product
    Table 58. Foamix Pharmaceuticals Ltd Recent Developments/Updates
    Table 59. Fujifilm Holdings Corporation Corporation Information
    Table 60. Fujifilm Holdings Corporation Description and Business Overview
    Table 61. Fujifilm Holdings Corporation Impetigo Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 62. Fujifilm Holdings Corporation Impetigo Drug Product
    Table 63. Fujifilm Holdings Corporation Recent Developments/Updates
    Table 64. Laboratories Ojer Pharma SL Corporation Information
    Table 65. Laboratories Ojer Pharma SL Description and Business Overview
    Table 66. Laboratories Ojer Pharma SL Impetigo Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 67. Laboratories Ojer Pharma SL Impetigo Drug Product
    Table 68. Laboratories Ojer Pharma SL Recent Developments/Updates
    Table 69. Lytix Biopharma AS Corporation Information
    Table 70. Lytix Biopharma AS Description and Business Overview
    Table 71. Lytix Biopharma AS Impetigo Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 72. Lytix Biopharma AS Impetigo Drug Product
    Table 73. Lytix Biopharma AS Recent Developments/Updates
    Table 74. Production Base and Market Concentration Rate of Raw Material
    Table 75. Key Suppliers of Raw Materials
    Table 76. Impetigo Drug Distributors List
    Table 77. Impetigo Drug Customers List
    Table 78. Impetigo Drug Market Trends
    Table 79. Impetigo Drug Market Drivers
    Table 80. Impetigo Drug Market Challenges
    Table 81. Impetigo Drug Market Restraints
    Table 82. Global Impetigo Drug Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 83. Global Impetigo Drug Sales Market Share Forecast by Type (2023-2028)
    Table 84. Global Impetigo Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 85. Global Impetigo Drug Revenue Market Share Forecast by Type (2023-2028)
    Table 86. Global Impetigo Drug Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 87. Global Impetigo Drug Sales Market Share Forecast by Application (2023-2028)
    Table 88. Global Impetigo Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 89. Global Impetigo Drug Revenue Market Share Forecast by Application (2023-2028)
    Table 90. Global Impetigo Drug Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 91. Global Impetigo Drug Sales Market Share Forecast by Region (2023-2028)
    Table 92. Global Impetigo Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 93. Global Impetigo Drug Revenue Market Share Forecast by Region (2023-2028)
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Impetigo Drug
    Figure 2. Global Impetigo Drug Market Share by Type in 2021 & 2028
    Figure 3. FMX-102 Product Picture
    Figure 4. LTX-109 Product Picture
    Figure 5. Mupirocin Product Picture
    Figure 6. Ozenoxacin Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Impetigo Drug Market Share by Application in 2021 & 2028
    Figure 9. Clinic
    Figure 10. Hospital
    Figure 11. Others
    Figure 12. Global Impetigo Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Impetigo Drug Market Size (2017-2028) & (US$ Million)
    Figure 14. Global Impetigo Drug Sales (2017-2028) & (K Pcs)
    Figure 15. Impetigo Drug Sales Share by Manufacturers in 2021
    Figure 16. Global Impetigo Drug Revenue Share by Manufacturers in 2021
    Figure 17. The Global 5 and 10 Largest Impetigo Drug Players: Market Share by Revenue in 2021
    Figure 18. Impetigo Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 19. Global Impetigo Drug Sales Market Share by Region (2017-2022)
    Figure 20. Global Impetigo Drug Sales Market Share by Region in 2021
    Figure 21. Global Impetigo Drug Revenue Market Share by Region (2017-2022)
    Figure 22. Global Impetigo Drug Revenue Market Share by Region in 2021
    Figure 23. U.S. Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Canada Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Germany Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. France Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. U.K. Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Italy Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Russia Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. China Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Japan Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. South Korea Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. India Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Australia Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Taiwan Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Indonesia Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Thailand Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Malaysia Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Philippines Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Vietnam Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Mexico Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Brazil Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Argentina Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Turkey Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Saudi Arabia Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. UAE Impetigo Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Sales Market Share of Impetigo Drug by Type (2017-2022)
    Figure 48. Manufacturing Cost Structure of Impetigo Drug
    Figure 49. Manufacturing Process Analysis of Impetigo Drug
    Figure 50. Impetigo Drug Industrial Chain Analysis
    Figure 51. Channels of Distribution
    Figure 52. Distributors Profiles
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Destiny Pharma Ltd
Foamix Pharmaceuticals Ltd
Fujifilm Holdings Corporation
Laboratories Ojer Pharma SL
Lytix Biopharma AS
Frequently Asked Questions
Impetigo Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Impetigo Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Impetigo Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports